Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Medicinal Products

Dáil Éireann Debate, Tuesday - 21 April 2026

Tuesday, 21 April 2026

Ceisteanna (732)

John Connolly

Ceist:

732. Deputy John Connolly asked the Minister for Health the reason long-term cancer medications, including hormone therapies used in cancer treatment and recurrence prevention, are not currently covered under the long-term illness scheme; whether consideration is being given to extending eligibility under the scheme to include such medications for cancer patients; whether consideration has been given to the automatic provision of a time-limited medical card to patients undergoing long-term cancer treatment (details supplied); and if she will make a statement on the matter. [27956/26]

Amharc ar fhreagra

Freagraí scríofa

The Long-Term Illness (LTI) Scheme was established under Section 59(3) of the Health Act 1970 (as amended). Regulations were made in 1971, 1973 and 1975, prescribing 16 conditions to be covered by the Scheme. The full list can be found here: www2.hse.ie/services/schemes-allowances/lti/approved-medications/

Under the LTI Scheme, patients receive drugs, medicines, and medical and surgical appliances directly related to the treatment of their illness, free of charge. While there are currently no plans to extend the list of conditions, it is important to remember that the LTI Scheme exists within a wider eligibility framework.

People who cannot, without undue hardship, arrange for the provision of medical services for themselves and their dependants may be eligible for a medical card under the General Medical Services (GMS) Scheme. In accordance with the provisions of the Health Act 1970 (as amended), eligibility for a medical card is determined by the HSE.

In certain circumstances the HSE may exercise discretion and grant a medical card, even though an applicant exceeds the income guidelines, where he or she faces difficult financial circumstances, such as extra costs arising from illness. The HSE afford applicants the opportunity to furnish supporting documentation to determine whether undue hardship exists and to fully take account of all relevant circumstances that may benefit them in assessment. In circumstances where an applicant is still over the income limit for a medical card, they are then assessed for a GP visit card, which entitles the applicant to GP visits without charge.

The issue of granting medical card eligibility based on having a particular disability or illness was previously examined in 2014 by the HSE Expert Panel on Medical Need and Medical Card Eligibility. The Group concluded that it was not feasible, desirable, nor ethically justifiable to list medical conditions in priority order for medical card eligibility. In following the Expert Group’s advice, a person’s means remains the main qualifier for a medical card.

For those without a medical card, under the Drugs Payment Scheme (DPS), no individual or family pays more than €80 a month towards the cost of approved prescribed medicines. The DPS is not means tested and is available to anyone ordinarily resident in Ireland. The DPS significantly reduces the cost burden for families and individuals with ongoing expenditure on medicines. Consideration of further changes to the DPS threshold will be made in the context of current healthcare priorities and the budget available.

There has been a significant focus on improving access to and the affordability of healthcare services over the last few years. This includes reductions in the DPS threshold, expansion of access to free GP care, and the abolition of all public in-patient hospital charges for children and adults. These measures continue to create a health and social care service that offers affordable access to quality healthcare.

Individuals may also be entitled to claim tax relief on the cost of their medical expenses, including medicines prescribed by a doctor, dentist, or consultant. Relief is at the standard tax rate of 20%.

Since 2017, the Government has allocated €105 million to the National Cancer Strategy itself to support cancer services and improve outcomes for patients. Since then, very significant progress has been made in improving cancer services and there are now over 220,000 living with or beyond cancer, 50% more than a decade ago.

A team external to the Department of Health will conduct an evaluation of the current strategy this year and the outcome of this will inform the development of the next strategy. The evaluation will inform the next steps to be taken and will be done in conjunction with stakeholders including the National Cancer Control Programme and the National Cancer Registry of Ireland. The new strategy will provide an important opportunity to plan for the introduction of new therapies and treatments across the cancer continuum from prevention, screening, treatment, survivorship and palliative care.

Roinn